FDA’s focus on the quality culture and its request for quality metrics may ensure a successful company-CMO relationship.
Jana Spes
Advertisement
Jana Spes is Vice-President, Technical Operations, Apotex, jspes@apotex.com.
Articles by Jana Spes
Advertisement
Latest Updated Articles
Quality Metrics and CMO AgreementMay 15th 2017
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
2
FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development
3
FDA Expands Anktiva Approval to Papillary-Only BCG-Unresponsive Bladder Cancer
4
Gilead Taps Vir Biotechnology's PRO-XTEN Tech for Solid Tumors
5